Frank Pessler

18PUBLICATIONS
44CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Epidemiological methodsCentral nervous systemPredictive and prognostic markersBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 20, 2026
NRF2 activators and the inhibitor of nuclear export, selinexor, restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1 through an NRF2-independent mechanism.

Fakhar H Waqas, Leandro Silva da Costa, Francisco J Zapatero-Belinchón

|Mar 26, 2025
Sex-specific and regional differences in the prevalence of diagnosed autoimmune diseases in Germany, 2022.

Manas K Akmatov, Claudia Kohring, Frank Pessler

|Jan 08, 2025
Vaccination Schedule and Age Influence Impaired Responsiveness to Hepatitis B Vaccination: A Randomized Trial in Central Asia.

Janyn Heisig, Zuridin Sh Nurmatov, Peggy Riese

|Jul 03, 2024
Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens.

Frieder Neu, Sandra Nay, Sven Schuchardt

|Nov 03, 2023
Elevated phospholipids and acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammation.

Amani Al-Mekhlafi, Fakhar H Waqas, Maike Krueger

|Jul 17, 2023
NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner.

Fakhar H Waqas, Mahmoud Shehata, Walid A M Elgaher

Pageof 3

Frequent Collaborators

5 joint publications

Fangfang Chen

2 joint publications

Konrad Büssow

2 joint publications

Manas K Akmatov

2 joint publications

Stephan Pleschka